切换至 "中华医学电子期刊资源库"

中华眼科医学杂志(电子版) ›› 2022, Vol. 12 ›› Issue (06) : 321 -325. doi: 10.3877/cma.j.issn.2095-2007.2022.06.001

述评

重视眼颅压力差在多学科领域的应用
王柠1,(), 王佳伟2, 刘旭阳3   
  1. 1. 350004 福州,福建医科大学附属第一医院神经内科
    2. 100730 首都医科大学附属北京同仁医院神经内科
    3. 361016 厦门大学附属厦门眼科中心青光眼科
  • 收稿日期:2022-11-19 出版日期:2022-12-28
  • 通信作者: 王柠
  • 基金资助:
    首都卫生发展科研专项基金项目(首发2020-2-2056)

Pay attention to the application of ocular-cranial pressure difference in multidisciplinary applications

Ning Wang1,(), Jiawei Wang2, Xuyang Liu3   

  1. 1. Department of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, China
    2. Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
    3. Department of Glaucoma, Xiamen Eye Center, Xiamen University, Xiamen 361016, China
  • Received:2022-11-19 Published:2022-12-28
  • Corresponding author: Ning Wang
引用本文:

王柠, 王佳伟, 刘旭阳. 重视眼颅压力差在多学科领域的应用[J]. 中华眼科医学杂志(电子版), 2022, 12(06): 321-325.

Ning Wang, Jiawei Wang, Xuyang Liu. Pay attention to the application of ocular-cranial pressure difference in multidisciplinary applications[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2022, 12(06): 321-325.

眼颅压力差是青光眼领域的热点问题,与正常眼压青光眼发病机制密切相关。眼颅压力差参考区间的提出,为正常眼压青光眼诊断与治疗的方案带来了重大更新。而该参考区间不但可应用于眼科临床,并且在神经外科中有关正常颅压性脑积水手术方案的制定;在神经内科中有关特发性颅高压视乳头水肿的防治;在航天医学中有关微重力相关眼病的诊断与治疗;在高原医学中有关高海拔视网膜疾病的诊断与治疗中均具有良好的应用前景。本文中笔者对眼颅压力差参考区间在多学科领域的应用现状和前景进行述评。

Ocular-cranial pressure difference is a hot topic in the field of glaucoma, and is closely related to the pathogenesis of normal-tension glaucoma. The proposed reference interval of ocular-cranial pressure difference brings a significant update to the treatment strategy of normal-tension glaucoma. The reference interval can be applied not only in ophthalmology, but also in neurosurgery, where the surgical plan for normal-pressure hydrocephalus is developed; in neurology, where the prevention and treatment of papilledema in idiopathic intracranial hypertension is performed; in aerospace medicine, where microgravity-related eye diseases are diagnosized and treated; and in high altitude medicine, where high altitude retinal diseases are diagnosized and treated. The current status and prospects of the application of ocular-cranial pressure difference reference interval in multidisciplinary fields were reviewed in this paper.

[1]
Jonas JB, Wang N, Yang D, et al. Facts and myths of cerebrospinal fluid pressure for the physiology of the eye[J]. Prog Retin Eye Res, 2015, 46: 67-83.
[2]
Pang R, Lin D, Di X, et al. Reference values for trans-laminar cribrosa pressure difference and its association with systemic biometric factors[J]. Eye (Lond), 2022, MID: 36481959.
[3]
Jóhannesson G, Eklund A, Lindén C. Intracranial and Intraocular Pressure at the Lamina Cribrosa: Gradient Effects[J]. Curr Neurol Neurosci Rep, 2018, 18(5): 25.
[4]
Berdahl JP, Yu DY, Morgan WH. The translaminar pressure gradient in sustained zero gravity, idiopathic intracranial hypertension, and glaucoma[J]. Med Hypotheses, 2012, 79(6): 719-724.
[5]
Volkov VV. Essential element of the glaucomatous process neglected in clinical practice[J]. Oftalmol Zh, 1976, 31(7): 500-504.
[6]
Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma[J]. Ophthalmology, 2008, 115(5): 763-768.
[7]
Ren R, Jonas JB, Tian G, et al. Cerebrospinal fluid pressure in glaucoma: a prospective study[J]. Ophthalmology, 2010, 117(2): 259-266.
[8]
Wang N, Xie X, Yang D, et al. Orbital cerebrospinal fluid space in glaucoma: the Beijing intracranial and intraocular pressure (iCOP) study[J]. Ophthalmology, 2012, 119(10): 2065-2073.
[9]
Liu H, Yang D, Ma T, et al. Measurement and associations of the optic nerve subarachnoid space in normal tension and primary open-angle glaucoma[J]. Am J Ophthalmol, 2018, 186: 128-137.
[10]
Jonas JB, Wang N, Wang YX, et al. Body height, estimated cerebrospinal fluid pressure and open-angle glaucoma. The Beijing Eye Study 2011[J]. PloS One, 2014, 9(1): e86678.
[11]
Jonas JB, Nangia V, Wang N, et al. Trans-lamina cribrosa pressure difference and open-angle glaucoma. The central India eye and medical study[J]. PloS One, 2013, 8(12): e82284.
[12]
Lee SH, Kwak SW, Kang EM, et al. Estimated trans-lamina cribrosa pressure differences in low-teen and high-teen intraocular pressure normal tension glaucoma: the korean national health and nutrition examination survey[J]. PloS One, 2016, 11(2): e0148412.
[13]
Yang D, Fu J, Hou R, et al. Optic neuropathy induced by experimentally reduced cerebrospinal fluid pressure in monkeys[J]. Invest Ophthalmol Vis Sci, 2014, 55(5): 3067-3073.
[14]
Zhang Z, Liu D, Jonas JB, et al. Axonal transport in the rat optic nerve following short-term reduction in cerebrospinal fluid pressure or elevation in intraocular pressure[J]. Invest Ophthalmol Vis Sci, 2015, 56(8): 4257-4266.
[15]
Liu X, Khodeiry MM, Lin D, et al. The association of acute cerebrospinal fluid pressure reduction with choroidal thickness[J]. Curr Eye Res, 2021, 46(8): 1193-1200.
[16]
Liu X, Khodeiry MM, LIN D, et al. The association of cerebrospinal fluid pressure with optic nerve head and macular vessel density[J]. Sci China Life Sci, 2022, 65(6): 1171-1180.
[17]
Gallina P, Savastano A, Becattini E, et al. Glaucoma in patients with shunt-treated normal pressure hydrocephalus[J]. J Neurosurg, 2018, 129(4): 1078-1084.
[18]
Wan Y, Wang H, Fan X, et al. Mechanosensitive channel Piezo1 is an essential regulator in cell cycle progression of optic nerve head astrocytes[J]. Glia, 2023, PMID: 36598105.
[19]
Balaratnasingam C, Morgan WH, Johnstone V, et al. Histomorphometric measurements in human and dog optic nerve and an estimation of optic nerve pressure gradients in human[J]. Exp Eye Res, 2009, 89(5): 618-628.
[20]
庞睿奇,林丹婷,李臻,等. 中国人眼颅压力梯度参考区间的临床研究[J]. 中华眼科医学杂志:电子版20199(5):267-272.
[21]
Hoehn R, Mirshahi A, Hoffmann EM, et al. Distribution of intraocular pressure and its association with ocular features and cardiovascular risk factors: the Gutenberg Health Study[J]. Ophthalmology, 2013, 120(5): 961-968.
[22]
Tomoyose E, Higa A, Sakai H, et al. Intraocular pressure and related systemic and ocular biometric factors in a population-based study in Japan: the Kumejima study[J]. Am J Ophthalmol, 2010, 150(2): 279-286.
[23]
Fleischman D, Berdahl JP, Zaydlarova J, et al. Cerebrospinal fluid pressure decreases with older age[J]. PloS one, 2012, 7(12): e52664.
[24]
Malm J, Jacobsson J, Birgander R, et al. Reference values for CSF outflow resistance and intracranial pressure in healthy elderly[J]. Neurology, 2011, 76(10): 903-909.
[25]
Li Z, Yang Y, Lu Y, et al. Intraocular pressure vs intracranial pressure in disease conditions: a prospective cohort study (Beijing iCOP study)[J]. BMC Neurol, 2012, 12: 66.
[26]
Killer HE, Pircher A. Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis[J]. Eye (Lond), 2018, 32(5): 924-930.
[27]
Lindén C, Qvarlander S, Jóhannesson G, et al. Normal-tension glaucoma has normal intracranial pressure: a prospective study of intracranial pressure and intraocular pressure in different body positions[J]. Ophthalmology, 2018, 125(3): 361-368.
[28]
Jaggi GP, Miller NR, Flammer J, et al. Optic nerve sheath diameter in normal-tension glaucoma patients[J]. Br J Ophthalmol, 2012, 96(1): 53-56.
[29]
Xie X, Zhang X, Fu J, et al. Noninvasive intracranial pressure estimation by orbital subarachnoid space measurement: the Beijing Intracranial and Intraocular Pressure (iCOP) study[J]. Crit Care, 2013, 17(4): R162.
[30]
Zhang Y, Cao K, Pang R, et al. Non-invasive intracranial pressure estimation using ultrasonographic measurement of area of optic nerve subarachnoid space[J]. Br J Ophthalmol, 2022, PMID: 36002239.
[31]
王宁利,刘含若,庞睿奇,等. 基于经眶超声的无创颅内压及眼颅压力梯度测量方法的操作规范[J]. 中华眼科医学杂志:电子版20199(1):61-64.
[32]
Pang R, Feng S, Cao K, et al. Association of serum retinol concentration with normal-tension glaucoma[J]. Eye (Lond), 2022, 36(9): 1820-1825.
[33]
Ren R, Wang N, Zhang X, et al. Cerebrospinal fluid pressure correlated with body mass index[J]. Graefes Arch Clin Exp Ophthalmol, 2012, 250(3): 445-446.
[34]
Ivancic R, Pfadenhauer K. Pseudotumor cerebri after hormonal emergency contraception[J]. Eur Neurol, 2004, 52(2): 120.
[35]
Marshall H, Berry EC, Torres SD, et al. Association between body mass index and primary open angle glaucoma in three cohorts[J]. Am J Ophthalmol, 2023, 245: 126-133.
[36]
Pasquale LR, Willett WC, Rosner BA, et al. Anthropometric measures and their relation to incident primary open-angle glaucoma[J]. Ophthalmology, 2010, 117(8): 1521-1529.
[37]
Li W, Pan J, Wei M, et al. Nonocular Influencing Factors for Primary Glaucoma: An Umbrella Review of Meta-Analysis[J]. Ophthalmic Res, 2021, 64(6): 938-950.
[38]
Han FF, Fu XX. Vitamin intake and glaucoma risk: A systematic review and meta-analysis[J]. J Fr Ophtalmol, 2022, 45(5): 519-528.
[39]
Ramdas WD, Schouten J, Webers CAB. The Effect of Vitamins on Glaucoma: A Systematic Review and Meta-Analysis[J]. Nutrients, 2018, 10(3): 359.
[40]
Wang LJ, Chen LM, Chen Y, et al. Ultrasonography Assessments of Optic Nerve Sheath Diameter as a Noninvasive and Dynamic Method of Detecting Changes in Intracranial Pressure[J]. JAMA ophthalmology, 2018, 136(3): 250-256.
[41]
田佳鑫,曹凯,石砚,等. 原发性开角型青光眼全身危险因素及眼体同治的系统回顾和Meta分析[J]. 中华眼科医学杂志:电子版20199(5):281-291.
[42]
庞睿奇,彭婕婷,王宁利. 原发性开角型青光眼的系统性危险因素[J]. 眼科202231(5):325-329.
[43]
Shalaby WS, Ahmed OM, Waisbourd M, et al. A review of potential novel glaucoma therapeutic options independent of intraocular pressure[J]. Surv Ophthalmol, 2022, 67(4): 1062-1080.
[44]
中华医学会眼科学分会青光眼学组,中国医师协会眼科医师分会青光眼学组. 中国青光眼指南(2020年)[J]. 中华眼科杂志202056(8):573-586.
[45]
Hamarat Y, Bartusis L, Deimantavicius M, et al. Can the Treatment of Normal-Pressure Hydrocephalus Induce Normal-Tension Glaucoma? A Narrative Review of a Current Knowledge[J]. Medicina (Kaunas), 2021, 57(3): 234.
[46]
Rudolph D, Sterker I, Graefe G, et al. Visual field constriction in children with shunt-treated hydrocephalus[J]. J Neurosurg Pediatr, 2010, 6(5): 481-485.
[47]
Chang TC, Singh K. Glaucomatous disease in patients with normal pressure hydrocephalus[J]. J Glaucoma, 2009, 18(3): 243-246.
[48]
Chen BH, Drucker MD, Louis KM, et al. Progression of normal-tension glaucoma after ventriculoperitoneal shunt to decrease cerebrospinal fluid pressure[J]. J Glaucoma, 2016, 25(1): e50-e52.
[49]
Yusuf IH, Ratnarajan G, Kerr RS, et al. Juvenile-onset normal tension glaucoma from chronic, recurrent low cerebrospinal fluid pressure[J]. J Glaucoma, 2016, 25(8): e738-e740.
[50]
Radke PM, Rubinstein TJ, Hamilton SR, et al. The translaminar pressure gradient: papilledema after trabeculectomy treated with optic nerve sheath fenestration[J]. J Glaucoma, 2018, 27(10): e154-e157.
[51]
Zhang LF, Hargens AR. Intraocular/Intracranial pressure mismatch hypothesis for visual impairment syndrome in space[J]. Aviat Space Environ Med, 2014, 85(1): 78-80.
[52]
沈羡云. 失重飞行对航天员身体的影响及防护措施(上)[J]. 中国航天20021:24-29.
[53]
黄海香,张文芳,律鹏. 高海拔视网膜病变及中药应用的研究进展[J]. 国际眼科杂志201414(11):1999-2002.
[1] 庞睿奇, 林丹婷, 李臻, 曹凯, 刘含若, 孙云晓, 万月, 王瑾, 杨一佺, 王宁利. 中国人眼颅压力梯度参考区间的临床研究[J]. 中华眼科医学杂志(电子版), 2019, 09(05): 267-272.
[2] 袁瑞, 楚淑芳, 余文辉, 宋林立, 许家瑞, 吴嘉, 张书楠, 张春雷. 基于大数据建立第三代促甲状腺激素生物参考区间及其与年龄和气候的相关性[J]. 中华临床医师杂志(电子版), 2021, 15(07): 491-496.
[3] 李克, 王峰. 特发性颅高压及相关眼病的诊疗进展[J]. 中华介入放射学电子杂志, 2020, 08(03): 221-226.
[4] 蔡锦河, 顾丽丽, 刘伟玲. 佛山地区健康成人血清尿素、肌酐参考区间的调查研究[J]. 中华临床实验室管理电子杂志, 2023, 11(03): 158-162.
[5] 余柏英, 黄颂恩, 何叶, 吴晓蔓, 吴红. 广州市1~6岁儿童甲状腺功能指标参考区间的研究[J]. 中华临床实验室管理电子杂志, 2021, 09(02): 80-83.
[6] 钟霓, 郭建, 慎慧, 张旻, 王莉莉, 郭文正, 王东江, 吴文娟. 曲霉IgG抗体的生物参考区间建立[J]. 中华临床实验室管理电子杂志, 2020, 08(03): 140-144.
[7] 张举, 张前春, 裴兵, 袁杭, 毛源, 陈传娇. 探讨建立江苏地区健康人群血清铁蛋白参考区间[J]. 中华临床实验室管理电子杂志, 2019, 07(04): 230-233.
阅读次数
全文


摘要